ACBI-4
Product Specifications
Target
Ras|||PROTACs
Related Pathways
MAPK|||PROTAC
Bioactivity
ACBI-4 is a selective PROTAC degrader targeting the active state of GTP-loaded KRAS (KRAS (on) ) . It demonstrates significant antiproliferative effects and effectively degrades various KRAS mutants in cancer cells, such as KRASG12R.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1402414-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1703.09 (SPBC1703.09)
Ask
View Details 
MBS1402414-02 0.1 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1703.09 (SPBC1703.09)
Ask
View Details 
MBS1402414-03 0.02 mg (Yeast)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1703.09 (SPBC1703.09)
Ask
View Details MBS1402414-04 0.1 mg (Yeast)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1703.09 (SPBC1703.09)
Ask
View Details 
MBS1402414-05 0.02 mg (Baculovirus)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1703.09 (SPBC1703.09)
Ask
View Details MBS1402414-06 0.02 mg (Mammalian-Cell)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1703.09 (SPBC1703.09)
Ask
View Details